30 March 2020

Coronavirus: ALERT on the use of chloroquine in myasthenia gravis

Please note: in myasthenia gravis, chloroquine, erythromycin and telithromycin are an absolute contraindication.

These treatments can make your condition worse and are likely to trigger a flare-up.

Find out more on the AFM website

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern